EP 4090174 A1 20221123 - A NUTRACEUTICAL FORMULATION
Title (en)
A NUTRACEUTICAL FORMULATION
Title (de)
NUTRAZEUTISCHE FORMULIERUNG
Title (fr)
FORMULATION NUTRACEUTIQUE
Publication
Application
Priority
- MY PI2021001876 A 20210406
- IB 2021054853 W 20210603
Abstract (en)
[origin: WO2022214861A1] The present invention discloses a nutraceutical formulation comprising phosphatidylcholine, cytidine diphosphate-choline, and choline alfoscerate, characterized in that, combination of the phosphatidycholine with cytidine diphosphate-choline and choline alfoscerate having synergistic effect in increasing choline bioavailability for supporting cognitive functions and cellular health.
IPC 8 full level
A23L 33/105 (2016.01); A23J 7/00 (2006.01); A23L 33/115 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01)
CPC (source: EP)
A23L 33/105 (2016.07); A23L 33/115 (2016.07); A23L 33/15 (2016.07); A23L 33/16 (2016.07); A23V 2002/00 (2013.01)
Citation (search report)
See references of WO 2022214861A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022214861 A1 20221013; CN 115443074 A 20221206; EP 4090174 A1 20221123
DOCDB simple family (application)
IB 2021054853 W 20210603; CN 202180001580 A 20210603; EP 21730452 A 20210603